Please ensure Javascript is enabled for purposes of website accessibility

Walgreens Boots Alliance Tops Q3 Earnings Estimates, but Growth Remains Elusive

By Keith Speights - Updated Jun 27, 2019 at 4:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The pharmacy giant continues to face major headwinds. But it managed to perform better than expected in Q3.

The last time Walgreens Boots Alliance (WBA 0.86%) announced its quarterly results, the pharmacy giant's revenue increased 4.6% compared to the prior-year period. It was a different story with adjusted earnings, though, which saw a year-over-year decline of 5.4%.

Walgreens announced its third-quarter results before the market opened on Thursday. The company's earnings fell yet again, but there was some good news. Here are the highlights from Walgreens' Q3 update.

Pharmacist speaking with client

Image source: Getty Images

By the numbers

Walgreens announced Q3 revenue of $34.6 billion, a 0.7% increase from the $34.3 billion reported in the year-ago period. The company's reported revenue was also slightly higher than analysts' average revenue estimate of $34.46 billion.

The pharmacy giant's net income reported under generally accepted accounting principles (GAAP) was $1.03 billion, or $1.13 per share, in the third quarter. This reflected a 16.5% decrease from the prior-year quarter.

Walgreens' non-GAAP (adjusted) net income came in at $1.47 per diluted share, a 4% year-over-year decline. However, the company beat analysts' consensus adjusted earnings estimate of $1.43 per share.

Behind the numbers

The weak revenue growth in the third quarter was hurt to some extent by currency fluctuations. Walgreens reported that its sales increased 2.9% from the prior-year period on a constant currency basis. This growth stemmed primarily from improvement in its U.S. retail pharmacy and pharmaceutical wholesale divisions. However, the company's international retail pharmacy division struggled with a poor performance from its Boots UK business.

Walgreens' operating expenses in Q3 matched the level from the prior-year quarter. With revenue increasing slightly and spending staying the same, why did the company's earnings decline? The main culprit was a lower gross margin resulting from a higher cost of sales in Q3.

Despite the mixed results, Walgreens Boots Alliance management expressed optimism. CEO Stefano Pessina stated, "Following a difficult second quarter, we made progress in the third quarter against the strategic goals we set, and are pleased to report an improvement in our U.S. comparable growth compared with the first half of the year."

Looking ahead

Walgreens maintained its guidance for fiscal 2019. The company still expects no significant earnings growth for the full year 2019 at constant currency rates. It also anticipates an adverse impact from currency fluctuations of $0.06 per share.

Pessina said that Walgreens Boots Alliance "will continue our aggressive response to rapidly shifting trends." The company is implementing what it calls a "transformational" cost-cutting program to help reduce expenses.

The big problem for Walgreens, though, is that cost reductions don't generate growth. They only help boost the bottom line temporarily. It's those "rapidly shifting trends" in the pharmacy industry Pessina mentioned that Walgreens really must deal with effectively for the company to return to solid growth.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
$40.96 (0.86%) $0.35

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.